Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05427201 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05427201: Completed NA study, sponsored by VA Office of Research and Development.
NCT05427201 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05427201, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Veterans with comorbid chronic pain and depression are highly prevalent, have poor functional status and low quality of life, are at increased risk of suicide and lack access to effective treatments. To address this problem, the proposed research will examine the feasibility of a novel approach that integrates repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy with the overall goal of maximizing functional improvement in Veterans with chronic pain and depression. This is an important first-step in preparation for a future randomized efficacy trial. The investigators will also include two cognitive control tasks with concurrent electroencephalography to explore as a potential objective indicator of treatment response. This application addresses a critical need within the Veterans Health Administration and is closely aligned with the focus area of developing suicide prevention treatments that influence participation in life roles.
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
- DEVICE Repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05427201
The ClinicalTrials.gov registry entry for NCT05427201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.
NCT05427201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05427201 about?
NCT05427201 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy". Veterans with comorbid chronic pain and depression are highly prevalent, have poor functional status and low quality of life, are at increased risk of suicide and lack access to effective treatments. To address this problem, the proposed research will examine the feasibility of a novel approach that...
What is the current status of trial NCT05427201?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-05-22. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT05427201?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05427201?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.